Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Personal Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes

NCT00404781 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT00404781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00404781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Personal Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes
Lead sponsor
Shenyang Northern Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2006
Completion date
June 30, 2007
Enrollment
305 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndromes, ischemic heart disease